EnVVeno Historical Financial Ratios
NVNO Stock | USD 2.79 0.07 2.45% |
EnVVeno Medical is recently reporting on over 90 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 68.15 will help investors to properly organize and evaluate enVVeno Medical Corp financial condition quickly.
EnVVeno |
About EnVVeno Financial Ratios Analysis
enVVeno Medical CorpFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate EnVVeno Medical investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on EnVVeno financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across EnVVeno Medical history.
EnVVeno Medical Financial Ratios Chart
Add Fundamental
Dividend Yield
Dividend Yield is enVVeno Medical Corp dividend as a percentage of EnVVeno Medical stock price. enVVeno Medical Corp dividend yield is a measure of EnVVeno Medical stock productivity, which can be interpreted as interest rate earned on an EnVVeno Medical investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Most ratios from EnVVeno Medical's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into enVVeno Medical Corp current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in enVVeno Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, EnVVeno Medical's Payables Turnover is very stable compared to the past year. As of the 19th of December 2024, Research And Ddevelopement To Revenue is likely to grow to 66.73, while Days Sales Outstanding is likely to drop 68.15.
2023 | 2024 (projected) | Payables Turnover | 1.28 | 1.34 | Days Of Inventory On Hand | 36.85 | 32.76 |
EnVVeno Medical fundamentals Correlations
Click cells to compare fundamentals
EnVVeno Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
EnVVeno Medical fundamentals Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Ptb Ratio | 8.76 | 1.57 | 1.05 | 1.48 | 1.37 | 1.44 | |
Book Value Per Share | 1.57 | 5.5 | 6.27 | 3.45 | 3.76 | 3.94 | |
Free Cash Flow Yield | (0.72) | (0.7) | (0.21) | (0.27) | (0.3) | (0.31) | |
Operating Cash Flow Per Share | (9.35) | (5.94) | (1.36) | (1.39) | (1.53) | (1.61) | |
Capex To Depreciation | 0.92 | 0.47 | 0.81 | 0.22 | 0.0604 | 0.0574 | |
Pb Ratio | 8.76 | 1.57 | 1.05 | 1.48 | 1.37 | 1.44 | |
Free Cash Flow Per Share | (9.93) | (6.08) | (1.41) | (1.4) | (1.54) | (1.61) | |
Roic | (6.68) | (1.2) | (0.3) | (0.63) | (0.54) | (0.57) | |
Net Income Per Share | (12.1) | (6.91) | (1.87) | (2.16) | (1.91) | (2.01) | |
Cash Per Share | 2.07 | 7.23 | 6.31 | 3.48 | 3.77 | 2.75 | |
Pocfratio | (1.47) | (1.46) | (4.83) | (3.67) | (3.35) | (3.19) | |
Capex To Operating Cash Flow | (0.0617) | (0.0235) | (0.0311) | (0.007363) | (0.00175) | (0.001662) | |
Pfcf Ratio | (1.38) | (1.42) | (4.68) | (3.64) | (3.35) | (3.18) | |
Income Quality | 0.77 | 0.84 | 0.72 | 0.63 | 0.8 | 0.55 | |
Roe | (7.7) | (1.26) | (0.3) | (0.63) | (0.51) | (0.53) | |
Ev To Operating Cash Flow | (1.39) | (0.35) | (0.38) | (3.49) | (3.24) | (3.07) | |
Pe Ratio | (1.14) | (1.25) | (3.53) | (2.36) | (2.69) | (2.82) | |
Return On Tangible Assets | (2.22) | (0.85) | (0.28) | (0.58) | (0.48) | (0.51) | |
Ev To Free Cash Flow | (1.31) | (0.35) | (0.37) | (3.46) | (3.23) | (3.07) | |
Earnings Yield | (0.88) | (0.8) | (0.28) | (0.42) | (0.37) | (0.39) | |
Net Debt To E B I T D A | 0.0647 | 0.97 | 3.15 | 0.12 | 0.0887 | 0.0842 | |
Current Ratio | 0.76 | 3.0 | 34.83 | 25.78 | 34.23 | 35.94 | |
Tangible Book Value Per Share | 1.57 | 5.5 | 6.27 | 3.45 | 3.76 | 3.94 | |
Graham Number | 20.67 | 29.22 | 16.22 | 12.96 | 12.71 | 12.07 | |
Shareholders Equity Per Share | 1.57 | 5.5 | 6.27 | 3.45 | 3.76 | 3.94 | |
Capex Per Share | 0.58 | 0.14 | 0.0424 | 0.0102 | 0.002683 | 0.002549 | |
Graham Net Net | (1.8) | 4.56 | 5.93 | 3.22 | 3.58 | 3.75 |
Pair Trading with EnVVeno Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EnVVeno Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EnVVeno Medical will appreciate offsetting losses from the drop in the long position's value.Moving against EnVVeno Stock
0.57 | ECOR | Electrocore LLC Upward Rally | PairCorr |
0.55 | MD | Mednax Inc | PairCorr |
0.49 | VREX | Varex Imaging Corp | PairCorr |
0.48 | OM | Outset Medical | PairCorr |
0.44 | DOCS | Doximity | PairCorr |
The ability to find closely correlated positions to EnVVeno Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EnVVeno Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EnVVeno Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling enVVeno Medical Corp to buy it.
The correlation of EnVVeno Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EnVVeno Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if enVVeno Medical Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for EnVVeno Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in enVVeno Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EnVVeno Medical. If investors know EnVVeno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EnVVeno Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.29) | Return On Assets (0.37) | Return On Equity (0.59) |
The market value of enVVeno Medical Corp is measured differently than its book value, which is the value of EnVVeno that is recorded on the company's balance sheet. Investors also form their own opinion of EnVVeno Medical's value that differs from its market value or its book value, called intrinsic value, which is EnVVeno Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EnVVeno Medical's market value can be influenced by many factors that don't directly affect EnVVeno Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EnVVeno Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if EnVVeno Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EnVVeno Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.